ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2024 | — | Replaced |
| 1st Quarter - Amendment | Mar 6, 2025 | $110,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -S. 652/H.R. 2630 the Safe Step Act -S. 3702/H.R. 7165 Credit for Caring Act -National Cholesterol Education Month and LDL-C Awareness Day -FDA Advisory Committee Meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee -Pharmacy benefit manager reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER New | — |
| MICHAEL WARD | — |
Medicare/Medicaid MMM
-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -S. 3109 the Alleviating Barriers for Caregivers Act -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Medicare Advantage Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and D Payment Policies and Draft Calendar Year (CY) 2025 Part D Redesign Instructions
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Budget/Appropriations BUD
-FY24 report language for the Food and Drug Administration -FY25 report language for the Food and Drug Administration -FY25 report language for the Medicare Program -National Institute of Allergy and Infectious Diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.